EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

The validation of advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in Turkish patients with classical Hodgkin lymphoma

Oguzhan Koca, Berk Ozyurt, Aysenur Umar, Deniz Ozmen, Tugrul Elverdi, Ayse Salihoglu, Muhlis Cem Ar, Zafer Baslar, Ahmet Emre Eskazan

Annals of Hematology · 2025-03 · 104 (3) · 1765-1775

DOI: 10.1007/s00277-025-06292-3 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Annals of Hematology, online erschienen am 12.03.2025. Verfasst von Oguzhan Koca und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey. Hauptthemen laut MEDLINE: Hodgkin Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Istanbul University Cerrahpaşa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In advanced-stage classical Hodgkin lymphoma (cHL), the prognosis has improved due to combination chemotherapy and PET/CT-guided treatment modification, resulting in a decreased prognostic capacity of IPS models. A novel model, A-HIPI, was found to be superior to IPS in predicting prognosis. In this study, we aimed to validate the A-HIPI model among Turkish cHL patients and compare its performance with other clinical prediction models. We retrospectively evaluated patients diagnosed with advanced-stage cHL between 2005 and 2018 at Istanbul University-Cerrahpaşa. We used IPS-7, IPS-3, and A-HIPI scores to calculate the C-index (Harrell’s Concordance Index) for discrimination; calibration intercept, and calibration slope for calibration. The models were compared using Akaike’s Information Criterion (AIC). Two hundred and seven patients were enrolled with a median follow-up of 75 months, 37 patients (17.9%) died. The 5-year PFS and OS were 66.6% and 84.9%, respectively. All three models were found to be prognostic for PFS and OS. The A-HIPI model was well-calibrated for PFS and OS in patients aged ≤65 years, but not calibrated for patients aged > 65 years. With A-HIPI, the respective C-index for PFS and OS was 0.605 and 0.740; whereas, for IPS-7 it was 0.598 and 0.684, and for IPS-3 it was 0.624 and 0.705. The lowest AIC value for OS was observed with the A-HIPI. The lowest AIC value for PFS was observed with IPS-3. This study validated the A-HIPI model in a homogeneous patient group for treatment protocol, with all follow-ups performed at a single center after the early 2000s in Turkey. The A-HIPI model demonstrated better performance than other models, except for patients aged > 65 years. A new clinical prediction model is needed for patients > 65 years, as IPS models are out of date and A-HIPI has not been validated for this group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hodgkin DiseaseHumansTurkeyMaleFemaleMiddle AgedAdultRetrospective StudiesAgedPrognosisAdolescentYoung AdultNeoplasm StagingAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

A-HIPIClinical prediction modelsIPSPrognosisPrognostic score

Autor:innen und Institutionen

  • Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey.
  • Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Fatih, Istanbul, Turkey.
  • Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Fatih, Istanbul, Turkey. emre.eskazan@iuc.edu.tr.

Förderung

  • Istanbul University Cerrahpaşa

Zitieren

APA

Koca, O., Ozyurt, B., Umar, A., Ozmen, D., Elverdi, T., Salihoglu, A., Ar, M. C., Baslar, Z., & Eskazan, A. E. (2025). The validation of advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in Turkish patients with classical Hodgkin lymphoma. Annals of Hematology, 104(3), 1765-1775. https://doi.org/10.1007/s00277-025-06292-3

Vancouver

Koca O, Ozyurt B, Umar A, Ozmen D, Elverdi T, Salihoglu A, et al. The validation of advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in Turkish patients with classical Hodgkin lymphoma. Annals of Hematology. 2025;104(3):1765-1775. doi:10.1007/s00277-025-06292-3

BibTeX
@article{Koca2025,
  author = {Koca, Oguzhan and Ozyurt, Berk and Umar, Aysenur and Ozmen, Deniz and Elverdi, Tugrul and Salihoglu, Ayse and Ar, Muhlis Cem and Baslar, Zafer and Eskazan, Ahmet Emre},
  title = {The validation of advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in Turkish patients with classical Hodgkin lymphoma},
  journal = {Annals of Hematology},
  year = {2025},
  volume = {104},
  number = {3},
  pages = {1765--1775},
  doi = {10.1007/s00277-025-06292-3}
}
Kostenlos starten →